Standard Biotools (LAB) Operating Margin Growth (5y) (2015 - 2026)
Standard Biotools (LAB) Operating Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn |
| 2 | Stryker | 127.31 Bn | 123.83 Bn | 4.50 Bn |
| 3 | Medtronic | 118.93 Bn | 109.71 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.35 Bn | 72.82 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn |
| 6 | Dexcom | 34.35 Bn | 32.40 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Standard Biotools | 252.86 Mn | -223.86 Mn | 10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6,895.00 |
| Mar 31, 2026 | -18.00 |
| Dec 31, 2025 | -6,567.00 |
| Sep 30, 2025 | -15,476.00 |
| Jun 30, 2025 | -6,541.00 |
| Mar 31, 2025 | -7,927.00 |
| Dec 31, 2024 | -7,697.00 |
| Sep 30, 2024 | -6,874.00 |
| Jun 30, 2024 | -8,263.00 |
| Mar 31, 2024 | -8,497.00 |
| Dec 31, 2023 | -4,147.00 |
| Sep 30, 2023 | -4,331.00 |
| Jun 30, 2023 | -1,469.00 |
| Mar 31, 2023 | -1,602.00 |
| Dec 31, 2022 | -4,665.00 |
| Sep 30, 2022 | -5,014.00 |
| Jun 30, 2022 | -13,642.00 |
| Mar 31, 2022 | -3,509.00 |
| Sep 30, 2021 | 2,241.00 |
| Jun 30, 2021 | 707.00 |